MAM
CBST

Myriad Asset Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Myriad Asset Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,644
Closed -$358K – 36
2013
Q3 		$358K Buy
+5,644
New +$341K 0.32% 12

Other funds holding CBST

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Myriad Asset Management's CBST Position: Q4 2013 in Review

Myriad Asset Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2013, closing a stake of 5,644 shares — an estimated $358K sold.

Myriad Asset Management first reported a position in CBST in Q3 2013 and held it in 1 quarter. The position peaked at $358K in Q3 2013. 276 funds tracked by Wall St. Rank hold CBST as of Q4 2013.

  • Myriad Asset Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Myriad Asset Management sold 5,644 CUBIST PHARMACEUTICALS INC shares in Q4 2013, an estimated $358K.
  • Myriad Asset Management first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2013 and held it in 1 quarter.
  • Myriad Asset Management's CUBIST PHARMACEUTICALS INC position peaked at $358K in Q3 2013.
  • 276 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2013.

Based on Myriad Asset Management's 13F filing for Q4 2013, filed 10 Feb 2014.